Home
Esportazione
Statistica
Opzioni
Visualizza tutti i metadati (visione tecnica)
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
Cazzaniga, Marina
•
Verusio, Claudio
•
Ciccarese, Mariangela
altro
Torri On Behalf Of The Eva Study Group, Valter
2018
journal article
Periodico
ONCOTARGET
Abstract
[This corrects the article DOI: 10.18632/oncotarget.25874.].
DOI
10.18632/oncotarget.26213
Archivio
http://hdl.handle.net/11368/2936356
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85054264901
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=26213&pubmed-linkout=1
Diritti
open access
license:creative commons
license uri:http://creativecommons.org/licenses/by/4.0/
FVG url
https://arts.units.it/bitstream/11368/2936356/1/correction everolimus-cazzaniga2018.pdf
Soggetti
Everolimu
advanced breast cance...
clinical practice
Scopus© citazioni
0
Data di acquisizione
Jun 7, 2022
Vedi dettagli
Visualizzazioni
2
Data di acquisizione
Apr 19, 2024
Vedi dettagli
google-scholar
Vedi dettagli